Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19"

Drugs. 2020 Sep;80(14):1501-1503. doi: 10.1007/s40265-020-01396-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections* / drug therapy
  • Humans
  • Immunomodulation
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Supplementary concepts

  • COVID-19 drug treatment